comparemela.com

Latest Breaking News On - Venture partners investment advisor - Page 3 : comparemela.com

Gracell Biotechnologies (NASDAQ:GRCL) Sees Unusually-High Trading Volume

Gracell Biotechnologies (NASDAQ:GRCL) Sees Unusually-High Trading Volume
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus
Piper-sandler
Wells-fargo-company
Bellevue-group
Cantor-fitzgerald
Tower-research-capital
Gracell-biotechnologies-company-profile
Gracell-biotechnologies-inc
Venture-partners-investment-advisor
Nasdaq
Gracell-biotechnologies
Get-free-report

Gracell Biotechnologies (NASDAQ:GRCL) Sees Strong Trading Volume

Gracell Biotechnologies (NASDAQ:GRCL) Sees Strong Trading Volume
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Stifel-nicolaus
Gracell-biotechnologies-inc
Gracell-biotechnologies-company-profile
Bellevue-group
Nasdaq
Venture-partners-investment-advisor
Wells-fargo-company
Tower-research-capital
Gracell-biotechnologies
Get-free-report
Street-group

Gracell Biotechnologies (NASDAQ:GRCL) Sees Strong Trading Volume

Shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) saw unusually-high trading volume on Monday . Approximately 1,123,772 shares were traded during trading, a decline of 14% from the previous session’s volume of 1,308,908 shares.The stock last traded at $10.17 and had previously closed at $10.06. Analysts Set New Price Targets GRCL has been […]

Piper-sandler
Wells-fargo-company
Venture-partners-investment-advisor
Nasdaq
Bellevue-group
Cantor-fitzgerald
Gracell-biotechnologies-inc
Tower-research-capital
Gracell-biotechnologies
Get-free-report
Street-group
Research-capital

Gracell Biotechnologies (NASDAQ:GRCL) Downgraded by HC Wainwright to Neutral

HC Wainwright lowered shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat.com reports. HC Wainwright currently has $10.00 target price on the stock, down from their previous target price of $13.00. HC Wainwright also issued estimates for Gracell […]

Stifel-nicolaus
Schonfeld-strategic-advisors
Tower-research-capital
Citigroup
Gracell-biotechnologies-inc
Venture-partners-investment-advisor
Cantor-fitzgerald
Nasdaq
Gracell-biotechnologies
Free-report
Gracell-biotechnologie
Moderate-buy

Piper Sandler Reaffirms "Neutral" Rating for Gracell Biotechnologies (NASDAQ:GRCL)

Gracell Biotechnologies (NASDAQ:GRCL – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at Piper Sandler in a report issued on Wednesday, Benzinga reports. They currently have a $10.00 target price on the stock. Piper Sandler’s price objective points to a potential upside of 0.81% from the company’s previous close. A number of […]

Stifel-nicolaus
Piper-sandler
Sphera-funds-management
Vivo-capital
Gracell-biotechnologies-inc
Gracell-biotechnologies-company-profile
Cantor-fitzgerald
Citigroup
Venture-partners-investment-advisor
Great-point-partners
Gracell-biotechnologies
Get-free-report

vimarsana © 2020. All Rights Reserved.